Evidence map›Paper›PMID 38551734›Full record

ReviewMolecular biology reports2024

Adenosine receptors in breast cancer.

Mahsa Mahdizadeh, Nadia Heydari, Afsaneh Shafiei, Hamideh Akbari, Seyyed Mehdi Jafari

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mahsa MahdizadehMetabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Nadia HeydariMetabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Afsaneh ShafieiMetabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Hamideh AkbariClinical Research Development Unit, Sayad Shirazi Hospital, Golestan University of Medical Science, Gorgan, Iran.
Seyyed Mehdi JafariMetabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran. s.meh.jafari@goums.ac.ir.ORCID http://orcid.org/0000-0003-0483-7505
Golestan University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenosine receptors are important in the normal physiological function of cells and the pathogenesis of various cancer cells, including breast cancer cells. The activity of adenosine receptors in cancer cells is related to cell proliferation, angiogenesis, metastasis, immune system evasion, and interference with apoptosis. Considering the different roles of adenosine receptors in cancer cells, we intend to investigate the function of adenosine receptors and their biological pathways in breast cancer to improve understanding of therapeutically relevant signaling pathways.

Indexed as

Breast NeoplasmsReceptor, Adenosine A3ApoptosisFemaleHumansReceptor, Adenosine A3A1 adenosine receptorA2A adenosine receptorA2B adenosine receptorA3 adenosine receptorBreast cancer

Identifiers

PMID38551734
OpenAlexW4393318353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.